Oncology News

ESMO oncology news ensures that you're always kept up to date with the latest developments that affect you and your daily practice. Make sure you check these pages frequently, or sign up to our newsletter.

Filter

Date Title Topic
28 Oct 2016 FDA Approves Pembrolizumab for First-Line Treatment of Metastatic NSCLC Lung and other thoracic tumours - Cancer Immunology and Immunotherapy
20 Oct 2016 FDA Approves Atezolizumab for Metastatic NSCLC Lung and other thoracic tumours - Cancer Immunology and Immunotherapy
19 Oct 2016 EMA Adopts a New Indication for Nivolumab Haematologic malignancies - Cancer Immunology and Immunotherapy
10 Oct 2016 ESMO 2016: PD-L1 Expression as a Biomarker for Checkpoint Inhibitors Response in Patients with Advanced Melanoma Melanoma and other skin tumours - Cancer Immunology and Immunotherapy
07 Oct 2016 ESMO 2016 Press Release: Neoadjuvant Immunotherapy Prior to Surgery is Safe and Feasible in Early Lung Cancer Lung and other thoracic tumours - Cancer Immunology and Immunotherapy
22 Aug 2016 Evolving Field of CAR-T-Cell Therapy Haematologic malignancies - Cancer Immunology and Immunotherapy
19 Aug 2016 CAR T Cell Therapy for Diffuse Large B Cell Lymphoma Included in EMA’s PRIority MEdicines Scheme Haematologic malignancies - Cancer Immunology and Immunotherapy
16 Aug 2016 CAR T-cells Targeting the CD4 Protein Granted FDA Orphan Drug Designation Haematologic malignancies - Cancer Immunology and Immunotherapy
12 Aug 2016 In Search of Biomarkers in Onco-Immunology Translational research - Cancer Immunology and Immunotherapy
09 Aug 2016 FDA Approves Pembrolizumab for Patients with Recurrent or Metastatic HNSCC with Disease Progression on or After Platinum-Containing Chemotherapy Head and neck cancers - Cancer Immunology and Immunotherapy
03 Aug 2016 NICE Issues Technology Appraisal Guidance for Nivolumab in Combination With Ipilimumab for Advanced Melanoma Melanoma and other skin tumours - Cancer Immunology and Immunotherapy
18 Jul 2016 Acquired Resistance to PD-1 Blockade in Melanoma Translational research - Melanoma and other skin tumours - Cancer Immunology and Immunotherapy
14 Jul 2016 World GI 2016 Press Release: The Debate on the Phase 3 Trial of MABp1 Presented at the 18th ESMO World Congress on Gastrointestinal Cancer Gastrointestinal cancers - Cancer Immunology and Immunotherapy
02 Jul 2016 World GI 2016 Press Release: Anti-Interleukin-1 Alpha Antibody MABp1 Improves Outcomes Significantly Over Placebo Gastrointestinal cancers - Cancer Immunology and Immunotherapy
29 Jun 2016 World GI 2016 Press Release: Anti-PD-L1 Immunotherapy Shows Response in Microsatellite-Stable Metastatic Colorectal Cancer in Combination with MEK Inhibition Gastrointestinal cancers - Cancer Immunology and Immunotherapy